The COVID-19 emergency showed how additive manufacturing crisis response can supplement conventional supply chains when demand rises faster than established production can adapt. Between February 15 and July 15, 2020, manufacturers, universities, hospitals, makerspaces, individuals, and other organizations used 3D printing to produce personal protective equipment (PPE), accessories, diagnostic supplies, and other items for healthcare communities across the United States.
The experience was not a substitute for established medical manufacturing. It was a distributed, rapidly organized effort that helped address specific shortages while revealing practical limits around production capacity, material availability, product approval, and coordination. Those lessons matter to industrial companies and healthcare organizations considering additive manufacturing as part of broader continuity and emergency planning.
Why additive manufacturing entered the response
Healthcare providers faced shortages of PPE, PPE accessories, and medical devices as the pandemic spread. The report identifies several contributing conditions: reliance on just-in-time manufacturing, an inadequate and poorly maintained national PPE stockpile, and dependence on globally sourced products from countries experiencing the same crisis.
The shortages affected more than major hospitals. Long-term care and nursing facilities, ambulatory health services, and social services were also part of the healthcare community in need. Items in short supply included N95 respirators, face shields, gowns, diagnostic nasal swabs, and ventilators. For N95 respirators, providers were directed to use crisis-capacity stockpile management and reuse practices.
Against this backdrop, two broad groups of non-traditional producers contributed. Pivot producers were manufacturing companies that redirected operations toward emergency items. Community producers included individuals, academic institutions, hospitals, makerspaces, and government agencies using available additive manufacturing equipment. Many relied on existing manufacturing expertise and shared designs to respond to needs in their regions.
What 3D printing suppliedâand where it fit
Face shields became one of the most widely produced additively manufactured PPE items and were readily used across the healthcare community. Ear savers and other non-medical accessories also found use because they did not replace designated medical devices. Meanwhile, printable nasal swabs, particularly nasopharyngeal swabs, helped some hospitals mitigate shortages of COVID-19 diagnostic supplies.
Face masks attracted early interest from non-traditional producers, but their role was more constrained. Because masks were critical to infection control, healthcare providers focused on managing N95 stocks and reuse strategies rather than treating additively manufactured masks as a direct replacement.
For the five-month period studied, the report estimated U.S. production of approximately 38 million face shield parts, 12 million nasal swabs, 2.5 million ear savers, 241,000 mask parts, and 116,000 ventilator parts. These are estimates of parts produced, not a claim that every item was interchangeable with, or appropriate for, every clinical application. The distinction is important when evaluating emergency manufacturing: a production total alone does not establish suitability for a particular use.
Coordination and design credibility shaped adoption
Non-traditional producers connected with organizations in need through social media, professional organizations, personal networks, and local relationships. Word-of-mouth was the most frequently reported significant source of connection: 53% of producers identified it as their leading route. This helped link distributed production to nearby recipients, but it also underscored how much the response depended on informal networks.
Shared design resources also played a role. Producers used the National Institutes of Health (NIH) 3D Print Exchange, while the COVID 3D TRUST brought together NIH/NIAID, the Food and Drug Administration, the Veterans Health Administration, and America Makes to evaluate designs posted to the Exchange. The report describes this effort as important to improving design credibility and quality. It identified a small number of designs as appropriate for emergency clinical use when made using specified printers and materials.
That qualification illustrates why healthcare adoption required more than access to a printable file. Healthcare organizations had low risk tolerance for equipment that was not FDA-compliant or NIOSH-certified. Guidance from trusted bodies helped address uncertainty for some products, including face shields and nasal swabs, but it did not remove the need to assess intended use, materials, manufacturing conditions, and applicable requirements.
Constraints on producers and healthcare organizations
Producers encountered shortages of additive manufacturing materials such as filament, limits on print throughput, and the difficulty of designing items suitable for high-risk medical settings. Additive manufacturing could respond flexibly to certain needs, but available machines and production speeds could not simply be assumed to meet demand for every category of PPE or medical device.
Healthcare organizations faced their own barriers. In addition to regulatory and safety concerns, they had to contend with uncertain demand, unclear timelines for the return of conventional supplies, and complex equipment acquisition processes. These conditions made it difficult to determine which additively manufactured items to obtain and when to use them.
Regional production and distribution helped some organizations receive supplies while traditional manufacturers worked to increase production. However, the effort required substantial labor and resources, and many producers needed external support. The response therefore depended not only on machines, but also on people, materials, design evaluation, communication, and routes to recipients.
Lessons for future crisis planning
The reportâs lessons point to steps for both manufacturing organizations and healthcare leaders:
- Build familiarity before an emergency. Healthcare organizations can engage with the additive manufacturing ecosystem for existing medical applications, such as patient-specific surgical needs, diagnostics, and education. Familiarity can help develop internal expertise before a crisis.
- Clarify risk and regulatory guidance. More guidance from regulatory bodies can help healthcare organizations understand risk thresholds for developing and using new products during emergencies. Producers also benefit from authoritative best practices for crisis manufacturing.
- Develop collaboration infrastructure. Online collaboration hubs supported much of the response. Reliable channels for sharing needs, designs, production knowledge, and recipient information can help turn distributed capacity into coordinated action.
- Plan for resources and limits. Emergency plans should account for labor, materials, machine throughput, product suitability, and the time required to connect producers with organizations in need.
Conclusion: flexibility depends on coordination
Additive manufacturingâs crisis value lies in its flexibility: it can offer options for what is produced, when production begins, and where it takes place. The COVID-19 response demonstrated that organizations across the country could mobilize this flexibility to address selected shortages. It also showed that production capacity alone is not enough. Clear communication, credible design evaluation, regulatory guidance, available materials, and coordination between producers and healthcare users are essential to making distributed manufacturing useful in an emergency.
Access Official Technical PDF